Company intelligence / Profile preview

Xihua Pharma

Shanghai, Shanghai, Chinaen.xihuasci.com ↗

Ownership: Private
Employees: ~340
Development stage: Phase 1

Overview

Xihua Pharma is a leading Chinese CDMO/CRO providing integrated solutions for pharmaceutical companies, including R&D, process development, analytical testing, clinical trial support, regulatory filing assistance, and commercial manufacturing for both innovative and generic drugs. The company supports small molecules, large molecules (biologics), gene therapies, cell therapies, and offers expertise across the full drug development lifecycle. It operates as a subsidiary of Shanghai Xihua Scientific Co., Ltd.

Modalities: Small moleculeLarge moleculeGene therapyCell therapy
Industry: Contract Research Organization

Partnerships

ArisGlobal/LifeSphere MultiVigilance for pharmacovigilance technology integration

Beyond the preview

Go deeper on Xihua Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xihua Pharma.

Explore the full profile